 |
인쇄하기
취소
|
Multiple myeloma therapy, ‘Kyprolis’ conducted Phase 3 clinical trials on Koreans
The new multiple myeloma therapy, ‘Kyprolis(carfilzomib, Amgen),’ will start a Phase 3 clinical trial adding 16 Korean subjects.
It has attracted interests of the industry since it is a newly-approved clinical trial targeting Koreans in the circumstance where the insurance benefit is about to be applied.
On the 3rd, the Ministry of Food and Drug Safety(MFDS) approved the Amgen’s Phase 3 head-...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.